期刊
BMJ-BRITISH MEDICAL JOURNAL
卷 350, 期 -, 页码 -出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/bmj.h1793
关键词
-
资金
- Alberta Advanced Education and Technology
- Alberta Innovates - Health Solutions (AHIS)
- Boiron
- Afexa Life Sciences
- Hecht Foundation
- HEEL
- Pfizer USA
- Schwabe Pharma
- Canadian Institutes for Health Research [86766]
- AHIS
- MRC [MR/J004871/1] Funding Source: UKRI
- Cancer Research UK [16895] Funding Source: researchfish
- Medical Research Council [MR/J004871/1] Funding Source: researchfish
N-of-1 trials are a useful tool for clinicians who want to determine the effectiveness of a treatment in a particular individual. The reporting of N-of-1 trials has been variable and incomplete, hindering their usefulness in clinical decision making and by future researchers. This document presents the CONSORT (Consolidated Standards of Reporting Trials) extension for N-of-1 trials (CENT 2015). CENT 2015 extends the CONSORT 2010 guidance to facilitate the preparation and appraisal of reports of an individual N-of-1 trial or a series of prospectively planned, multiple, crossover N-of-1 trials. CENT 2015 elaborates on 14 items of the CONSORT 2010 checklist, totalling 25 checklist items (44 sub-items), and recommends diagrams to help authors document the progress of one participant through a trial or more than one participant through a trial or series of trials, as applicable. Examples of good reporting and evidence based rationale for CENT 2015 checklist items are provided.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据